Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-18

Clinical Trial Update: High Intensity Lipid Lowering Following Acute Coronary Syndromes for Persons Living With HIV [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated high intensity lipid lowering in people living with HIV after acute coronary syndromes; status completed with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Matthew Feinstein | Conditions: HIV Infection, Coronary Heart Disease | Phase 2 | Status: COMPLETED | Results posted: 2022-10-18